8-A12B: Registration of securities [Section 12(b)]
Published on November 4, 2021
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIORESTORATIVE THERAPIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
91-1835664
|
(State of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
||
40 Marcus Drive, Suite One, Melville, New York
|
|
11747
|
(Address of principal executive offices)
|
|
(Zip Code)
|
If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ⌧
If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ☐
Securities Act registration statement file number to which this form relates: No. 333-258611
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class
to be so registered
|
Name of each exchange on which
each class is to be registered
|
|
Common Stock (par value $0.0001 per share)
|
|
The Nasdaq Stock Market LLC
|
Securities to be registered pursuant to Section 12(g) of the Act: None.
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of the Registrant’s Securities to be Registered.
Incorporated by reference to Registrant’s registration statement on Form S-1/A, as filed on October 29, 2021 (File
No. 333-258611).
Item 2. Exhibits.
None.
|
||
|
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto
duly authorized.
BIORESTORATIVE THERAPIES. INC.
|
|
|
|
|
|
Date: November 3, 2021
|
By: /s/
|
|
Name: Lance Alstodt
|
|
Title: Chief Executive Officer
|